Cargando…
A novel BMI-1 inhibitor QW24 for the treatment of stem-like colorectal cancer
BACKGROUND: Cancer-initiating cell (CIC), a functionally homogeneous stem-like cell population, is resonsible for driving the tumor maintenance and metastasis, and is a source of chemotherapy and radiation-therapy resistance within tumors. Targeting CICs self-renewal has been proposed as a therapeut...
Autores principales: | Wang, Jinhua, Xing, Yajing, Wang, Yingying, He, Yundong, Wang, Liting, Peng, Shihong, Yang, Lianfang, Xie, Jiuqing, Li, Xiaotao, Qiu, Wenwei, Yi, Zhengfang, Liu, Mingyao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6805542/ https://www.ncbi.nlm.nih.gov/pubmed/31640758 http://dx.doi.org/10.1186/s13046-019-1392-8 |
Ejemplares similares
-
Lycorine is a novel inhibitor of the growth and metastasis of hormone-refractory prostate cancer
por: Hu, Meichun, et al.
Publicado: (2015) -
Pancreatitis Incidence in the Exenatide BID, Exenatide QW, and Exenatide QW Suspension Development Programs: Pooled Analysis of 35 Clinical Trials
por: Vetter, Marion L., et al.
Publicado: (2019) -
Ailanthone targets p23 to overcome MDV3100 resistance in castration-resistant prostate cancer
por: He, Yundong, et al.
Publicado: (2016) -
Ailanthone: a new potential drug for castration-resistant prostate cancer
por: Peng, Shihong, et al.
Publicado: (2017) -
Synthesis and biological evaluation of 3-nitro-4-chromanone derivatives as potential antiproliferative agents for castration-resistant prostate cancer
por: Chen, Huiqing, et al.
Publicado: (2019)